查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
甲癣全球市场规模、份额、行业趋势分析报告，按类型（远端甲下、近端甲下、白色表面、其他）、治疗方法（局部、口服、其他）、区域前景预测，2022-2028 年
市场调查报告书
商品编码
1245505

甲癣全球市场规模、份额、行业趋势分析报告，按类型（远端甲下、近端甲下、白色表面、其他）、治疗方法（局部、口服、其他）、区域前景预测，2022-2028 年

Global Onychomycosis Market Size, Share & Industry Trends Analysis Report By Type (Distal Subungual, Proximal Subungual, White Superficial and Others), By Treatment (Topical, Oral and Others), By Regional Outlook and Forecast, 2022 - 2028
出版日期: | 出版商: KBV Research | 英文 164 Pages | 订单完成后即时交付

价格

到 2028 年，甲真菌病的全球市场规模预计将达到 45 亿美元，预测期内復合年增长率为 4.8%。

近端甲下甲真菌病 (PSO) 的致病菌首先侵入近端甲板的下侧，然后向远端扩散。 内生甲癣（EO）也指没有甲床感染的真菌侵入甲板。 完全营养不良性甲真菌病 (TDO) 可能会出现其他亚型，并且是甲真菌病的最后阶段。 继发性甲真菌病（SO），临床上类似于非真菌性和真菌性甲病，继发于非真菌性甲病（即牛皮癣）的复杂真菌感染。

COVID-19 影响分析

随着越来越多的医院和初级保健诊所转向 COVID-19 患者，大流行减少了诊断数量并影响了药物和其他甲真菌病治疗的销售。我是。 COVID-19 还影响了人们的免疫力，使他们更容易感染甲癣等真菌病。 它还使已经感染的人復发的风险增加了一倍。 因此，大流行对甲癣市场产生了负面影响。

市场增长因素

管道中潜在候选药物的研发不断增加

甲癣的患病率不断上升，而且缺乏有效的治疗方法，这推动了对更好的药物疗法的需求。 许多非处方局部药物不能深入指甲板，因此无法完全治愈感染。 因此，许多公司都在努力寻找能够深入指甲的化合物来克服这一挑战。 许多公司正在积极致力于开发新疗法，包括 BB2603 (Blueberry Therapeutics)、Hallux Terbinafine Subungual Gel 和 MOB-015 (Moberg Pharma)。

皮肤癣菌甲癣的患病率上升

甲癣发病率的增加是市场扩张的主要驱动力之一。 甲癣比指甲甲癣更常见。 由皮肤癣菌引起的甲癣患病率上升和处方的显着增加正在推动对甲癣药物的需求。 甲癣影响世界上很大一部分人口并折磨数百万人。 导致甲癣增加的另一个因素是糖尿病发病率的上升。 因此，在未来几年，所有这些因素都将推动甲癣治疗的需求，从而使市场受益。

市场製约因素

低需求弹性和非危及生命的条件

此外，由于皮肤癣菌性甲癣不会危及生命且治疗效果低，因此来自无效替代疗法的竞争越来越激烈。 例如，茶树油是一种越来越多地用于治疗指甲感染的替代品。 由于潜在的显着副作用，目前被批准作为甲癣治疗选择的药物需要进行肝臟筛查和监测。 因此，对治疗药物的需求下降可能会阻碍市场扩张。

按类型划分的前景

按类型，甲真菌病市场分为远端甲下、白色浅表、近端甲下等。 到 2021 年，远端甲下部分将在甲癣市场中占据最高的收入份额。 由于需求增加和仿製药渗透率上升，该领域的主导地位与 FDA 批准更多仿製药有关。 此外，更多药物正在研发中，以满足对有效药物日益增长的需求。 最常见的甲癣类型是远端甲下。 在这种情况下，甲真菌病区的近端边缘变得参差不齐，黄白色的尖刺突出到甲板上。

治疗前景

根据治疗方法，甲癣市场分为口服、外用和其他。 2021 年，口服药物在甲癣市场的收入份额最大。 该细分市场正在增长，因为与其他形式的抗真菌药物相比，口服药物不仅具有更高的治疗治愈率，而且治疗持续时间更短。 例如，口服盐酸特比□芬是治疗甲癣最常用的药物。 此外，一些仿製药製造商正在推出口服药物来对抗不断上升的甲癣发病率。 例如，茶碱缓释 (ER) 片于 2021 年 6 月获得美国 FDA 批准。

区域展望

按地区分析了北美、欧洲、亚太地区和 LAMEA 的甲癣市场。 2021 年，北美市场在甲癣市场的收入份额最大。 该地区甲真菌病发病率的增加和有益的政府政策可能是增长的因素。 在发达国家中，北美是人均医疗保健费用最高的国家之一。 此外，北美有很多人患有甲癣。 不断上升的发病率增加了对有效治疗甲真菌病以对抗甲真菌病的需求。 正因为如此，美国公司正在斥巨资开发这些药物。

内容

第一章市场范围与研究方法

  • 市场定义
  • 目的
  • 市场范围
  • 细分
    • 全球甲癣市场，按类型
    • 全球甲癣市场，按治疗分类
    • 全球甲癣市场，按地区
  • 调查方法

第 2 章市场概述

  • 介绍
    • 概览
      • 市场构成和情景
  • 影响市场的主要因素
    • 市场驱动因素
    • 市场製约因素

第 3 章全球甲癣市场：按类型

  • 全球远端甲下市场：按地区
  • 全球近端甲下市场，按地区
  • 全球白色表面模具市场，按地区划分
  • 按地区、世界其他地区市场

第 4 章全球甲癣市场：按治疗

  • 全球外用市场：按地区
  • 全球口腔市场：按地区
  • 按地区划分的其他全球市场

第 5 章全球甲癣市场：按地区划分的市场

  • 北美
    • 北美甲癣市场：按国家/地区列出
      • 美国
      • 加拿大
      • 墨西哥
      • 其他北美地区
  • 欧洲
    • 欧洲甲癣市场：按国家/地区分类
      • 德国
      • 英国
      • 法国
      • 俄罗斯
      • 西班牙
      • 意大利
      • 其他欧洲
  • 亚太地区
    • 按国家/地区划分的亚太甲真菌病市场
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 新加坡
      • 其他亚太地区
  • 拉美
    • LAMEA 甲癣市场：按国家/地区分类
      • 巴西
      • 阿根廷
      • 阿联酋
      • 沙特阿拉伯
      • 南非
      • 尼日利亚
      • LAMEA 的其余部分

第六章公司简介

  • Abbott Laboratories
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC（GSK）
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Novartis AG

The Global Onychomycosis Market size is expected to reach $4.5 billion by 2028, rising at a market growth of 4.8% CAGR during the forecast period.

A fungal infection of nails called onychomycosis results in thickening and discoloration of the nail plate. In general, the word onychomycosis covers infections caused by yeasts, saprophytic molds, and dermatophytes in addition to dermatophytes. Though fingernails, as well as toenails, can get infected, toenail onychomycosis is more common. Recent studies have shown that mixed infections and infections brought on by non-dermatophyte molds (NDMs) are more common, particularly in warmer climates.

The dermatophyte-induced onychomycosis condition is known as tinea unguium. Subtypes of onychomycosis are categorized according to the invasion pattern. The most prevalent form of onychomycosis, known as distal subungual onychomycosis (DSO), happens when the fungus colonizes the distal portion of the nail plate. Fungi infiltrate the nail plate's outermost layers in superficial white onychomycosis (SWO).

The organism that causes proximal subungual onychomycosis (PSO) first invades from the underside of the proximal nail fold, then the infection subsequently spreads distally. Additionally, Endonyx onychomycosis (EO) refers to the nail plate's fungal invasion that does not involve nail bed infection. Total dystrophic onychomycosis (TDO), which may follow any other subtypes, is the final stage of onychomycosis. Clinically resembling both the non-fungal and fungal nail disorders, secondary onychomycosis (SO) refers to the non-fungal nail condition (that is, psoriasis) along with a secondary fungal infection.

COVID-19 Impact Analysis

As many hospital institutions and primary care clinics switched their attention to COVID-19 patients, the pandemic led to a decline in diagnoses and had an impact on the sales of medications and other onychomycosis treatment options. In addition, COVID-19 also affected the immunity of people, which increased the chances for acquiring fungal diseases like onychomycosis. The risk of recurrence also multiplied for people who already had the infection. Therefore, the pandemic had an adverse impact on the onychomycosis market.

Market Growth Factors

Rising research and development of potential candidates in the pipeline

The rising prevalence of onychomycosis coupled with a lack of viable treatments have increased the demand for better medication. Many of the topical medications on the market cannot reach the depths of the nail bed, making it impossible to entirely heal the infection. As a result, many businesses are trying hard to find compounds that penetrate the nails deeper to overcome this difficulty. Numerous businesses are actively developing new treatments, including BB2603 (Blueberry Therapeutics), Hallux Terbinafine Subungual Gel, and MOB-015 (Moberg Pharma).

Growing prevalence of dermatophytic onychomycosis

Onychomycosis' increasing incidence is one of the major factors propelling the market's expansion. Infection of the toenail onychomycosis is far more common than that of the fingernails. The rising prevalence of dermatophyte-caused nail fungal infections and a large rise in the number of prescriptions are propelling the demand for onychomycosis treatment. A significant number of the world's population has onychomycosis, with millions suffering from nail fungus. A further factor contributing to the rise in dermatophytic infection is the rising incidence of diabetes. Hence, in the coming years, all these factors will expedite the need for onychomycosis treatment, which would benefit the market.

Market Restraining Factors

Low demand elasticity and non-life-threatening condition

The non-life-threatening characteristics of dermatophytic onychomycosis and the treatment's poor efficacy have also led to intense competition from ineffective alternative treatment methods. For instance, tea tree oil is a substitute product that is increasingly utilized to treat nail infections. Since the current medications licensed for the treatment option of onychomycosis have the potential for significant side effects, liver screening and monitoring are necessary. Therefore, the lower demand for the treatment have the potential to hamper the expansion of the market.

Type Outlook

Based on type, the onychomycosis market is categorized into distal subungual, white superficial, proximal subungual, and others. The distal subungual segment garnered the highest revenue share in the onychomycosis market in 2021. The segment's dominance is linked to the FDA's clearance of more generic drugs due to rising demand and rising generic prevalence. Additionally, there are more pharmaceuticals in the pipeline to address the increased demand for effective medications. The most typical kind of onychomycosis is distal subungual. In this, the onycholytic area's proximal edge is ragged, and yellow-white spikes protrude into the nail plate.

Treatment Outlook

On the basis of treatment, the onychomycosis market is divided into oral, topical, and others. The oral segment recorded a significant revenue share in the onychomycosis market in 2021. The segment is growing since oral medications have greater treatment cure rates as well as shorter treatment periods than other forms of antifungals. For example, terbinafine hydrochloride oral medication is the most used treatment for onychomycosis. Additionally, to combat the rising incidence of onychomycosis, some generic drug makers are introducing oral medicines. Theophylline extended-release (ER) tablets, for example, were approved by the U.S. FDA in June 2021.

Regional Outlook

Based on region, the onychomycosis market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the maximum revenue share in the onychomycosis market in 2021. Onychomycosis's increased frequency in the region as well as helpful government policies can be attributed to the growth. Among the developed nations, North America has one of the highest per capita healthcare costs. Additionally, many people in North America have onychomycosis. The rising incidence rate is increasing the need for effective onychomycosis treatments in the fight against the disease. Due to this, American businesses have made large expenditures in the creation of these medications.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, Bausch Health Companies, Inc., Bayer AG, Cipla Limited, Merck & Co., Inc., Novartis AG, Sun Pharmaceutical Industries Ltd., and GlaxoSmithKline PLC.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Distal Subungual
  • Proximal Subungual
  • White Superficial
  • Others

By Treatment

  • Topical
  • Oral
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Singapore
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Pfizer, Inc.
  • Teva Pharmaceuticals Industries Ltd.
  • Abbott Laboratories
  • Bausch Health Companies, Inc.
  • Bayer AG
  • Cipla Limited
  • Merck & Co., Inc.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline PLC

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Onychomycosis Market, by Type
    • 1.4.2 Global Onychomycosis Market, by Treatment
    • 1.4.3 Global Onychomycosis Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Onychomycosis Market by Type

  • 3.1 Global Distal Subungual Market by Region
  • 3.2 Global Proximal Subungual Market by Region
  • 3.3 Global White Superficial Market by Region
  • 3.4 Global Others Market by Region

Chapter 4. Global Onychomycosis Market by Treatment

  • 4.1 Global Topical Market by Region
  • 4.2 Global Oral Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Onychomycosis Market by Region

  • 5.1 North America Onychomycosis Market
    • 5.1.1 North America Onychomycosis Market by Type
      • 5.1.1.1 North America Distal Subungual Market by Country
      • 5.1.1.2 North America Proximal Subungual Market by Country
      • 5.1.1.3 North America White Superficial Market by Country
      • 5.1.1.4 North America Others Market by Country
    • 5.1.2 North America Onychomycosis Market by Treatment
      • 5.1.2.1 North America Topical Market by Country
      • 5.1.2.2 North America Oral Market by Country
      • 5.1.2.3 North America Others Market by Country
    • 5.1.3 North America Onychomycosis Market by Country
      • 5.1.3.1 US Onychomycosis Market
        • 5.1.3.1.1 US Onychomycosis Market by Type
        • 5.1.3.1.2 US Onychomycosis Market by Treatment
      • 5.1.3.2 Canada Onychomycosis Market
        • 5.1.3.2.1 Canada Onychomycosis Market by Type
        • 5.1.3.2.2 Canada Onychomycosis Market by Treatment
      • 5.1.3.3 Mexico Onychomycosis Market
        • 5.1.3.3.1 Mexico Onychomycosis Market by Type
        • 5.1.3.3.2 Mexico Onychomycosis Market by Treatment
      • 5.1.3.4 Rest of North America Onychomycosis Market
        • 5.1.3.4.1 Rest of North America Onychomycosis Market by Type
        • 5.1.3.4.2 Rest of North America Onychomycosis Market by Treatment
  • 5.2 Europe Onychomycosis Market
    • 5.2.1 Europe Onychomycosis Market by Type
      • 5.2.1.1 Europe Distal Subungual Market by Country
      • 5.2.1.2 Europe Proximal Subungual Market by Country
      • 5.2.1.3 Europe White Superficial Market by Country
      • 5.2.1.4 Europe Others Market by Country
    • 5.2.2 Europe Onychomycosis Market by Treatment
      • 5.2.2.1 Europe Topical Market by Country
      • 5.2.2.2 Europe Oral Market by Country
      • 5.2.2.3 Europe Others Market by Country
    • 5.2.3 Europe Onychomycosis Market by Country
      • 5.2.3.1 Germany Onychomycosis Market
        • 5.2.3.1.1 Germany Onychomycosis Market by Type
        • 5.2.3.1.2 Germany Onychomycosis Market by Treatment
      • 5.2.3.2 UK Onychomycosis Market
        • 5.2.3.2.1 UK Onychomycosis Market by Type
        • 5.2.3.2.2 UK Onychomycosis Market by Treatment
      • 5.2.3.3 France Onychomycosis Market
        • 5.2.3.3.1 France Onychomycosis Market by Type
        • 5.2.3.3.2 France Onychomycosis Market by Treatment
      • 5.2.3.4 Russia Onychomycosis Market
        • 5.2.3.4.1 Russia Onychomycosis Market by Type
        • 5.2.3.4.2 Russia Onychomycosis Market by Treatment
      • 5.2.3.5 Spain Onychomycosis Market
        • 5.2.3.5.1 Spain Onychomycosis Market by Type
        • 5.2.3.5.2 Spain Onychomycosis Market by Treatment
      • 5.2.3.6 Italy Onychomycosis Market
        • 5.2.3.6.1 Italy Onychomycosis Market by Type
        • 5.2.3.6.2 Italy Onychomycosis Market by Treatment
      • 5.2.3.7 Rest of Europe Onychomycosis Market
        • 5.2.3.7.1 Rest of Europe Onychomycosis Market by Type
        • 5.2.3.7.2 Rest of Europe Onychomycosis Market by Treatment
  • 5.3 Asia Pacific Onychomycosis Market
    • 5.3.1 Asia Pacific Onychomycosis Market by Type
      • 5.3.1.1 Asia Pacific Distal Subungual Market by Country
      • 5.3.1.2 Asia Pacific Proximal Subungual Market by Country
      • 5.3.1.3 Asia Pacific White Superficial Market by Country
      • 5.3.1.4 Asia Pacific Others Market by Country
    • 5.3.2 Asia Pacific Onychomycosis Market by Treatment
      • 5.3.2.1 Asia Pacific Topical Market by Country
      • 5.3.2.2 Asia Pacific Oral Market by Country
      • 5.3.2.3 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Onychomycosis Market by Country
      • 5.3.3.1 China Onychomycosis Market
        • 5.3.3.1.1 China Onychomycosis Market by Type
        • 5.3.3.1.2 China Onychomycosis Market by Treatment
      • 5.3.3.2 Japan Onychomycosis Market
        • 5.3.3.2.1 Japan Onychomycosis Market by Type
        • 5.3.3.2.2 Japan Onychomycosis Market by Treatment
      • 5.3.3.3 India Onychomycosis Market
        • 5.3.3.3.1 India Onychomycosis Market by Type
        • 5.3.3.3.2 India Onychomycosis Market by Treatment
      • 5.3.3.4 Australia Onychomycosis Market
        • 5.3.3.4.1 Australia Onychomycosis Market by Type
        • 5.3.3.4.2 Australia Onychomycosis Market by Treatment
      • 5.3.3.5 South Korea Onychomycosis Market
        • 5.3.3.5.1 South Korea Onychomycosis Market by Type
        • 5.3.3.5.2 South Korea Onychomycosis Market by Treatment
      • 5.3.3.6 Singapore Onychomycosis Market
        • 5.3.3.6.1 Singapore Onychomycosis Market by Type
        • 5.3.3.6.2 Singapore Onychomycosis Market by Treatment
      • 5.3.3.7 Rest of Asia Pacific Onychomycosis Market
        • 5.3.3.7.1 Rest of Asia Pacific Onychomycosis Market by Type
        • 5.3.3.7.2 Rest of Asia Pacific Onychomycosis Market by Treatment
  • 5.4 LAMEA Onychomycosis Market
    • 5.4.1 LAMEA Onychomycosis Market by Type
      • 5.4.1.1 LAMEA Distal Subungual Market by Country
      • 5.4.1.2 LAMEA Proximal Subungual Market by Country
      • 5.4.1.3 LAMEA White Superficial Market by Country
      • 5.4.1.4 LAMEA Others Market by Country
    • 5.4.2 LAMEA Onychomycosis Market by Treatment
      • 5.4.2.1 LAMEA Topical Market by Country
      • 5.4.2.2 LAMEA Oral Market by Country
      • 5.4.2.3 LAMEA Others Market by Country
    • 5.4.3 LAMEA Onychomycosis Market by Country
      • 5.4.3.1 Brazil Onychomycosis Market
        • 5.4.3.1.1 Brazil Onychomycosis Market by Type
        • 5.4.3.1.2 Brazil Onychomycosis Market by Treatment
      • 5.4.3.2 Argentina Onychomycosis Market
        • 5.4.3.2.1 Argentina Onychomycosis Market by Type
        • 5.4.3.2.2 Argentina Onychomycosis Market by Treatment
      • 5.4.3.3 UAE Onychomycosis Market
        • 5.4.3.3.1 UAE Onychomycosis Market by Type
        • 5.4.3.3.2 UAE Onychomycosis Market by Treatment
      • 5.4.3.4 Saudi Arabia Onychomycosis Market
        • 5.4.3.4.1 Saudi Arabia Onychomycosis Market by Type
        • 5.4.3.4.2 Saudi Arabia Onychomycosis Market by Treatment
      • 5.4.3.5 South Africa Onychomycosis Market
        • 5.4.3.5.1 South Africa Onychomycosis Market by Type
        • 5.4.3.5.2 South Africa Onychomycosis Market by Treatment
      • 5.4.3.6 Nigeria Onychomycosis Market
        • 5.4.3.6.1 Nigeria Onychomycosis Market by Type
        • 5.4.3.6.2 Nigeria Onychomycosis Market by Treatment
      • 5.4.3.7 Rest of LAMEA Onychomycosis Market
        • 5.4.3.7.1 Rest of LAMEA Onychomycosis Market by Type
        • 5.4.3.7.2 Rest of LAMEA Onychomycosis Market by Treatment

Chapter 6. Company Profiles

  • 6.1 Abbott Laboratories
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.5 SWOT Analysis
  • 6.2 Bausch Health Companies, Inc.
    • 6.2.1 Company Overview
    • 6.2.2 Financial Analysis
    • 6.2.3 Segmental and Regional Analysis
    • 6.2.4 Research & Development Expense
    • 6.2.5 Recent strategies and developments:
      • 6.2.5.1 Trials and Approvals:
  • 6.3 Bayer AG
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expense
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Product Launches and Expansions:
  • 6.4 Cipla Limited
    • 6.4.1 Company Overview
    • 6.4.2 Financial Analysis
    • 6.4.3 Regional Analysis
    • 6.4.4 Research & Development Expense
    • 6.4.5 Recent strategies and developments:
      • 6.4.5.1 Product Launches and Product Expansions:
  • 6.5 Sun Pharmaceutical Industries Ltd.
    • 6.5.1 Company Overview
    • 6.5.2 Financial Analysis
    • 6.5.3 Regional & Segmental Analysis
    • 6.5.4 Research & Development Expenses
    • 6.5.5 Recent strategies and developments:
      • 6.5.5.1 Acquisition and Mergers:
  • 6.6 GlaxoSmithKline PLC (GSK)
    • 6.6.1 Company Overview
    • 6.6.2 Financial Analysis
    • 6.6.3 Segmental and Regional Analysis
    • 6.6.4 Research & Development Expense
    • 6.6.5 Recent strategies and developments:
      • 6.6.5.1 Partnerships, Collaborations, and Agreements:
  • 6.7 Pfizer, Inc.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Regional & Segmental Analysis
    • 6.7.4 Research & Development Expense
  • 6.8 Teva Pharmaceutical Industries Ltd.
    • 6.8.1 Company Overview
    • 6.8.2 Financial Analysis
    • 6.8.3 Regional Analysis
    • 6.8.4 Research & Development Expenses
  • 6.9 Merck & Co., Inc.
    • 6.9.1 Company Overview
    • 6.9.2 Financial Analysis
    • 6.9.3 Segmental and Regional Analysis
    • 6.9.4 Research & Development Expenses
  • 6.10. Novartis AG
    • 6.10.1 Company Overview
    • 6.10.2 Financial Analysis
    • 6.10.3 Segmental and Regional Analysis
    • 6.10.4 Research & Development Expense

LIST OF TABLES

  • TABLE 1 Global Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 2 Global Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 3 Global Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 4 Global Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 5 Global Distal Subungual Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Distal Subungual Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Proximal Subungual Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Proximal Subungual Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global White Superficial Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global White Superficial Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 12 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 13 Global Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 14 Global Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 15 Global Topical Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Topical Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Oral Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Oral Market by Region, 2022 - 2028, USD Million
  • TABLE 19 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 20 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 21 Global Onychomycosis Market by Region, 2018 - 2021, USD Million
  • TABLE 22 Global Onychomycosis Market by Region, 2022 - 2028, USD Million
  • TABLE 23 North America Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 24 North America Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 25 North America Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 26 North America Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 27 North America Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 36 North America Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 37 North America Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 44 North America Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 45 US Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 46 US Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 47 US Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 48 US Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 49 US Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 50 US Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 51 Canada Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 52 Canada Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 53 Canada Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 54 Canada Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 55 Canada Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 56 Canada Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 57 Mexico Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 58 Mexico Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 59 Mexico Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 60 Mexico Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 61 Mexico Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 62 Mexico Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 63 Rest of North America Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 64 Rest of North America Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 65 Rest of North America Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 66 Rest of North America Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 67 Rest of North America Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 68 Rest of North America Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 69 Europe Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 70 Europe Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 71 Europe Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 72 Europe Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 73 Europe Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 74 Europe Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 75 Europe Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 76 Europe Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 77 Europe White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 80 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 81 Europe Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 82 Europe Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 83 Europe Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 84 Europe Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 85 Europe Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 86 Europe Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 87 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 88 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 89 Europe Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 90 Europe Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 91 Germany Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 92 Germany Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 93 Germany Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 94 Germany Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 95 Germany Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 96 Germany Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 97 UK Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 98 UK Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 99 UK Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 100 UK Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 101 UK Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 102 UK Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 103 France Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 104 France Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 105 France Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 106 France Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 107 France Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 108 France Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 109 Russia Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 110 Russia Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 111 Russia Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 112 Russia Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 113 Russia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 114 Russia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 115 Spain Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 116 Spain Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 117 Spain Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 118 Spain Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 119 Spain Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 120 Spain Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 121 Italy Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 122 Italy Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 123 Italy Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 124 Italy Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 125 Italy Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 126 Italy Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 127 Rest of Europe Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 128 Rest of Europe Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 129 Rest of Europe Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 130 Rest of Europe Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 131 Rest of Europe Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 132 Rest of Europe Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 139 Asia Pacific Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 140 Asia Pacific Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 141 Asia Pacific White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 142 Asia Pacific White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 143 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 144 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 145 Asia Pacific Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 146 Asia Pacific Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 147 Asia Pacific Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 148 Asia Pacific Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 149 Asia Pacific Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 150 Asia Pacific Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 151 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 152 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 153 Asia Pacific Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 154 Asia Pacific Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 155 China Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 156 China Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 157 China Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 158 China Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 159 China Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 160 China Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 161 Japan Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 162 Japan Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 163 Japan Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 164 Japan Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 165 Japan Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 166 Japan Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 167 India Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 168 India Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 169 India Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 170 India Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 171 India Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 172 India Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 173 Australia Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 174 Australia Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 175 Australia Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 176 Australia Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 177 Australia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 178 Australia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 179 South Korea Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 180 South Korea Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 181 South Korea Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 182 South Korea Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 183 South Korea Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 184 South Korea Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 185 Singapore Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 186 Singapore Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 187 Singapore Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 188 Singapore Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 189 Singapore Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 190 Singapore Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 191 Rest of Asia Pacific Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 192 Rest of Asia Pacific Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 193 Rest of Asia Pacific Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 194 Rest of Asia Pacific Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 195 Rest of Asia Pacific Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 196 Rest of Asia Pacific Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 199 LAMEA Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 200 LAMEA Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 201 LAMEA Distal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 202 LAMEA Distal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 203 LAMEA Proximal Subungual Market by Country, 2018 - 2021, USD Million
  • TABLE 204 LAMEA Proximal Subungual Market by Country, 2022 - 2028, USD Million
  • TABLE 205 LAMEA White Superficial Market by Country, 2018 - 2021, USD Million
  • TABLE 206 LAMEA White Superficial Market by Country, 2022 - 2028, USD Million
  • TABLE 207 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 208 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 209 LAMEA Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 210 LAMEA Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 211 LAMEA Topical Market by Country, 2018 - 2021, USD Million
  • TABLE 212 LAMEA Topical Market by Country, 2022 - 2028, USD Million
  • TABLE 213 LAMEA Oral Market by Country, 2018 - 2021, USD Million
  • TABLE 214 LAMEA Oral Market by Country, 2022 - 2028, USD Million
  • TABLE 215 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 216 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 217 LAMEA Onychomycosis Market by Country, 2018 - 2021, USD Million
  • TABLE 218 LAMEA Onychomycosis Market by Country, 2022 - 2028, USD Million
  • TABLE 219 Brazil Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 220 Brazil Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 221 Brazil Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 222 Brazil Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 223 Brazil Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 224 Brazil Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 225 Argentina Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 226 Argentina Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 227 Argentina Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 228 Argentina Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 229 Argentina Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 230 Argentina Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 231 UAE Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 232 UAE Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 233 UAE Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 234 UAE Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 235 UAE Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 236 UAE Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 237 Saudi Arabia Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 238 Saudi Arabia Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 239 Saudi Arabia Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 240 Saudi Arabia Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 241 Saudi Arabia Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 242 Saudi Arabia Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 243 South Africa Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 244 South Africa Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 245 South Africa Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 246 South Africa Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 247 South Africa Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 248 South Africa Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 249 Nigeria Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 250 Nigeria Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 251 Nigeria Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 252 Nigeria Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 253 Nigeria Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 254 Nigeria Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 255 Rest of LAMEA Onychomycosis Market, 2018 - 2021, USD Million
  • TABLE 256 Rest of LAMEA Onychomycosis Market, 2022 - 2028, USD Million
  • TABLE 257 Rest of LAMEA Onychomycosis Market by Type, 2018 - 2021, USD Million
  • TABLE 258 Rest of LAMEA Onychomycosis Market by Type, 2022 - 2028, USD Million
  • TABLE 259 Rest of LAMEA Onychomycosis Market by Treatment, 2018 - 2021, USD Million
  • TABLE 260 Rest of LAMEA Onychomycosis Market by Treatment, 2022 - 2028, USD Million
  • TABLE 261 Key Information - Abbott Laboratories
  • TABLE 262 key information - Bausch Health Companies, Inc.
  • TABLE 263 Key Information - Bayer AG
  • TABLE 264 Key Information - Cipla Limited
  • TABLE 265 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 266 Key Information - GlaxoSmithKline PLC (GSK)
  • TABLE 267 Key Information - Pfizer, Inc.
  • TABLE 268 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 269 KEY INFORMATION - Merck & Co., Inc.
  • TABLE 270 Key Information - Novartis AG

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Onychomycosis Market Share by Type, 2021
  • FIG 3 Global Onychomycosis Market Share by Type, 2028
  • FIG 4 Global Onychomycosis Market by Type, 2018 - 2028, USD Million
  • FIG 5 Global Onychomycosis Market Share by Treatment, 2021
  • FIG 6 Global Onychomycosis Market Share by Treatment, 2028
  • FIG 7 Global Onychomycosis Market by Treatment, 2018 - 2028, USD Million
  • FIG 8 Global Onychomycosis Market Share by Region, 2021
  • FIG 9 Global Onychomycosis Market Share by Region, 2028
  • FIG 10 Global Onychomycosis Market by Region, 2018 - 2028, USD Million
  • FIG 11 Swot analysis: Abbott laboratories